Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Crescent Biopharma (CBIO) Receivables - Net (2025)

Crescent Biopharma (CBIO) has disclosed Receivables - Net for 2 consecutive years, with $18.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net changed N/A to $18.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.0 million, a N/A change, with the full-year FY2025 number at $18.0 million, changed N/A from a year prior.
  • Receivables - Net was $18.0 million for Q4 2025 at Crescent Biopharma, down from $20.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $18.0 million in Q4 2025 to a low of $18.0 million in Q4 2025.